The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Heinz Baumann sits on this spectrum.
This scientist: 237 publications — 63rd percentile
63% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Heinz Baumann sits on this spectrum.
This scientist: 88 D-Index — 87th percentile
87% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Heinz Baumann is affiliated with the Roswell Park Cancer Institute in the United States. Their research spans several areas within medicine and biochemistry, focusing strongly on aspects of photodynamic therapy, molecular biology, and cardiovascular issues related to pregnancy and venous thromboembolism.
The main fields of study in Baumann's work include Medicine and Biochemistry, Genetics and Molecular Biology, with subfields covering Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Biomedical Engineering, Materials Chemistry, and Internal Medicine.
Baumann's recent scholarly output includes publications in notable journals. Recent papers include:
Frequent co-authors in Baumann's research include Ravindra R. Cheruku, Erin Tracy, Ravindra K. Pandey, Walter A. Tabaczynski, and Joseph R. Missert, suggesting collaborative work especially in areas related to photodynamic therapy and cancer treatment.
Baumann has published multiple articles in various venues, with recurring contributions to the Journal of Medicinal Chemistry, Geburtshilfe und Frauenheilkunde, and the International Journal of Molecular Sciences.
The main research topics addressed by Baumann involve:
This range of topics reflects an interdisciplinary approach combining clinical cardiology, cancer therapy, and molecular research techniques. Baumann's work on photodynamic therapy, particularly involving pyropheophorbide conjugates, links chemical and biological strategies to tumor-targeted treatments.
Heinz Baumann;Jack Gauldie
Manfred Kopf;Heinz Baumann;Giulia Freer;Marina Freudenberg
Z Xing;J Gauldie;G Cox;H Baumann
Jack Gauldie;Carl Richards;Del Harnish;Peter Lansdorp
Heinz Baumann;Karen K. Morella;David W. White;Marlene Dembski
Akhilesh Pandey;Katsutoshi Ozaki;Heinz Baumann;Steven D. Levin
Tino Hochepied;Franklin G Berger;Heinz Baumann;Claude Libert
W E Carson;T A Fehniger;S Haldar;K Eckhert
H Baumann;J Gauldie
Mustafa Benekli;Maria R Baer;Heinz Baumann;Meir Wetzler
H Baumann;C Richards;J Gauldie
S O Gollnick;S S Evans;H Baumann;B Owczarczak
David W. White;Karen K. Kuropatwinski;Rene Devos;Heinz Baumann
S Marinkovic;G P Jahreis;G G Wong;H Baumann
H Baumann;G G Wong
Brendan John Jenkins;Dianne Grail;Thao Nheu;Meri Najdovska
Baumann H;Prowse Kr;Marinković S;Won Ka
H Baumann;V Onorato;J Gauldie;G P Jahreis
Qing Chen;Daniel T Fisher;Kristen A Clancy;Jean-Marc M Gauguet
H Baumann;P Schendel
If you think any of the details on this page are incorrect, let us know.
National Institutes for Quantum and Radiological Science and Technology
Publications: 63
Tokyo Institute of Technology
Pohang University of Science and Technology
Spanish National Research Council
Sharif University of Technology
University of the Basque Country
Federal University of Rio de Janeiro
Princess Margaret Cancer Centre
University of Newcastle Australia
The University of Texas at Dallas
University of California, Los Angeles
University of A Coruña
Battelle
Rensselaer Polytechnic Institute
Duke University
University of Perugia
Medical University of Vienna
